Europe Vagus Nerve Stimulation Market - Industry Trends and Forecast to 2029

Europe Vagus Nerve Stimulation Market - Industry Trends and Forecast to 2029

Europe vagus nerve stimulation market is projected to register a substantial CAGR of 15.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation

Europe Vagus Nerve Stimulation Market, By Product Type (Implantable VNS Devices and External VNS Devices), Biomaterial (Ceramics, Metallic, and Polymerics), Application (Pain Management, Epileptic Seizures, Obesity Management, Depression and Anxiety, and Others), Patient Type (Adults, Pediatric, and Geriatric), End User (Hospitals, Ambulatory Surgical Centers, Specialty Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and Rest of Europe) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the Europe vagus nerve stimulation market are:
• Increasing prevalence and incidence of neurological disorders
• Innovative non-invasive Vagus Nerve Stimulation (nVNS) devices introduced to meet the demand
• Rise in product approvals
• Product development in recent years

Market Players

Some of the key market players in the Europe vagus nerve stimulation market are listed below:
• electroCore, Inc.
• LivaNova PLC
• Medtronic
• SetPoint Medical
• tVNS Technologies GmbH
• Brain Control Co. Limited
• Cirtec
• MicroTransponder Inc.
• Others

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.